Joseph Aquilina
Barts Health NHS Trust
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph Aquilina.
Ultrasound in Obstetrics & Gynecology | 2014
L. Velauthar; Maria N. Plana; M. Kalidindi; Javier Zamora; B. Thilaganathan; S. E. Illanes; Khalid S. Khan; Joseph Aquilina; Shakila Thangaratinam
To determine the accuracy with which uterine artery Doppler in the first trimester of pregnancy predicts pre‐eclampsia and fetal growth restriction, particularly early‐onset disease.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2014
Rebecca Allen; Ewelina Rogozinska; Kirsty Cleverly; Joseph Aquilina; Shakila Thangaratinam
OBJECTIVE Our aim was to evaluate the strength of association between abnormal levels of first trimester maternal blood biomarkers and the risk of preeclampsia. STUDY DESIGN We searched MEDLINE, EMBASE and Cochrane databases from inception until April 2013. Studies that assessed the association between any abnormal maternal blood biomarker in the first trimester and preeclampsia were included. Two independent reviewers selected studies, extracted data and assessed the quality. Results were summarized as pooled odds ratios with 95% confidence intervals. RESULTS From 1071 citations, we identified 30 studies (65,538 women) for inclusion. Twenty four studies assessed preeclampsia of any onset, 10 studied early onset preeclampsia and seven evaluated late onset preeclampsia (after 34 weeks of gestation). The biomarkers PAPP-A (OR 2.1, 95% CI 1.6, 2.6), PP13 (OR 4.4, 95% CI 2.9, 6.8), sFlt-1 (OR 1.3, 95% CI 2.9, 6.8), pentraxin (OR 5.3, 95% CI 1.9, 15.0) and inhibin-A (OR 3.6, 95% CI 1.7, 7.6) were significantly associated with any preeclampsia. The odds of early onset preeclampsia were significantly increased when the biomarkers PlGF (OR 3.4, 95% CI 1.6, 7.2), PAPP-A (OR 4.8, 95% CI 2.5, 22.5), PP13 (OR 7.5, 95% CI 2.5, 22.5), soluble endoglin (OR 18.5, 95% CI 8.4, 41.0) and inhibin-A (OR 4.1, 95% CI 1.9, 8.8) were abnormal. Two biomarkers, soluble endoglin (OR 2.1, 95% CI 1.9, 2.4) and inhibin-A (OR 1.9, 95% CI 1.4, 2.8) were significantly associated with late onset preeclampsia. CONCLUSION Abnormal maternal blood biomarkers in early pregnancy are significantly associated with preeclampsia, particularly early onset disease.
Ultrasound in Obstetrics & Gynecology | 2013
L. Velauthar; Maria N. Plana; M. Kalidindi; Javier Zamora; B. Thilaganathan; S. E. Illanes; Khalid S. Khan; Joseph Aquilina; Shakila Thangaratinam
To determine the accuracy with which uterine artery Doppler in the first trimester of pregnancy predicts pre‐eclampsia and fetal growth restriction, particularly early‐onset disease.
Journal of Maternal-fetal & Neonatal Medicine | 2018
Rebecca Allen; Joseph Aquilina
Abstract Objectives: To assess the efficacy of biomarkers, arteriography and uterine artery Dopplers for predicting hypertensive disease of pregnancy, small for gestational age (SGA) and stillbirth. Methods: This was a prospective first-trimester study. Ultrasound was used to assess uterine artery Doppler. Maternal arteriography was performed and serum was taken for the measurement of placental growth factor (PlGF), alpha-fetoprotein (AFP), pregnancy-associated plasma protein (PAPP-A) and beta-human chorionic gonadotrophin levels. Logistic regression with stepwise selection was performed to determine multivariate models. Results: One thousand and forty-five women were left for analysis after exclusions. Fourteen developed preeclampsia, 23 pregnancy induced hypertension, 64 SGA <5th centile, 118 SGA <10th centile and three stillbirth. Systolic blood pressure (SBP) in the aorta (SBPAO) (p = .002) was significantly associated with preeclampsia. Detection rate (DR) was 72% for a false-positive rate (FPR) of 15%, an area under the curve (AUC) of 0.81, 95% CI 0.69–0.93. MAP and maternal weight (p = .001) were significantly associated with PIH. DR 48%, AUC 0.76, 95% CI 0.65–0.86. Low PAPP-A and PlGF were significantly associated with SGA <10th centile (p = .007 and .004, respectively), DR 30%, AUC 0.608, 95% CI 0.54–0.68. SGA <5th centile was significantly associated with low PlGF (p = <.001), DR 57%, AUC 0.73, 95% CI 0.65–0.80. Conclusions: No association was found between first-trimester biomarkers and preeclampsia/PIH. There was a significant association between low PlGF and PAPP-A and SGA.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2018
Shemoon Marleen; Janitha Hettiarachchi; Ranmalie Dandeniya; Rebecca Macgreggor; Joseph Aquilina; Asma Khalil; Joshua P. Vogel; Ana Pilar Betrán; Shakila Thangaratinam
In twin pregnancies, which are at high risk of preterm birth, it is not known if maternal clinical characteristics pose additional risks. We undertook a systematic review to assess the risk of both spontaneous and iatrogenic early (<34 weeks) or late preterm birth (<37 weeks) in twin pregnancies based on maternal clinical predictors. We searched the electronic databases from January 1990 to November 2017 without language restrictions. We included studies on women with monochorionic or dichorionic twin pregnancies that evaluated clinical predictors and preterm births. We reported our findings as odds ratio (OR) with 95% confidence intervals (CI) and pooled the estimates using random-effects meta-analysis for various predictor thresholds. From 12, 473 citations, we included 59 studies (2,930,958 pregnancies). The risks of early preterm birth in twin pregnancies were significantly increased in women with a previous history of preterm birth (OR 2.67, 95% CI 2.16-3.29, I2 = 0%), teenagers (OR 1.81, 95% CI 1.68-1.95, I2 = 0%), BMI > 35 (OR 1.63, 95% CI 1.30-2.05, I2 = 52%), nulliparous (OR 1.51, 95% CI 1.38-1.65, I2 = 73%), non-white vs. white (OR 1.31, 95% CI 1.20-1.43, I2 = 0%), black vs. non-black (OR 1.38, 95% CI 1.07-1.77, I2 = 98%), diabetes (OR 1.73, 95% CI 1.29-2.33, I2 = 0%) and smokers (OR 1.30, 95% CI 1.23-1.37, I2 = 0%). The odds of late preterm birth were also increased in women with history of preterm birth (OR 3.08, 95% CI 2.10-4.51, I2 = 73%), teenagers (OR 1.36, 95% CI 1.18-1.57, I2 = 57%), BMI > 35 (OR 1.18, 95% CI 1.02-1.35, I2 = 46%), nulliparous (OR 1.41, 95% CI 1.23-1.62, I2 = 68%), diabetes (OR 1.44, 95% CI 1.05-1.98, I2 = 55%) and hypertension (OR 1.49, CI 1.20-1.86, I2 = 52%). The additional risks posed by maternal clinical characteristics for early and late preterm birth should be taken into account while counseling and managing women with twin pregnancies.
Ultrasound in Obstetrics & Gynecology | 2014
L. Velauthar; Maria N. Plana; M. Kalidindi; Javier Zamora; B. Thilaganathan; S. E. Illanes; Khalid S. Khan; Joseph Aquilina; Shakila Thangaratinam
To determine the accuracy with which uterine artery Doppler in the first trimester of pregnancy predicts pre‐eclampsia and fetal growth restriction, particularly early‐onset disease.
Ultrasound in Obstetrics & Gynecology | 2001
Joseph Aquilina; O. Thompson; B. Thilaganathan; Kevin Harrington
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2017
Rebecca Allen; Javier Zamora; David Arroyo-Manzano; Luxmilar Velauthar; John Allotey; Shakila Thangaratinam; Joseph Aquilina
Ultrasound in Obstetrics & Gynecology | 2016
Rebecca Allen; Jonathan P. Bestwick; Shakila Thangaratinam; Joseph Aquilina
Ultrasound in Obstetrics & Gynecology | 2014
F.S. Marleen; I. Shahid; A.A. Hashi; A. Rebecca; Joseph Aquilina